ATH
Click for more information
0.00% 0.3¢ alterity therapeutics limited

Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease, page-4

  1. Cowanna
    82 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    01/06/15
    10:34
    Post #: 15387768
    adding to the question of approval of sale does this approval also apply to Japan and Asia, or are they
    determined by the US FDA. Is the Australian market also dependent on the US approval.
    PBT Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $45.28K 15.09M

Buyers (Bids)

No. Vol. Price($)
58 101407102 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 17448796 5
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.